OAB-055: Updated results of a phase 1, first-in-human study of ABBV-383, a BCMA × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma
Year: 2022
Type: conference-abstract
Authors: Peter Voorhees, Nina Shah, Anita D’Souza, Cesar Rodriguez, Katja Weisel, Raphael Teipel, David Hurd, Orlando Bueno, Neil Pumford, Tanya Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy Ross, Akshanth Polepally, Shane Lee, Ziyi Jin, Chetasi Talati, Shaji Kumar, Ravi Vij
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4293087221